Skoči na glavni sadržaj

Izvorni znanstveni članak

https://doi.org/10.20471/acc.2019.58.s2.02

Prostate-Specific Antigen (PSA) Values in Patients with Low- and High-Risk Prostatic Adenocarcinoma

Silvija Mašić ; Ljudevit Jurak Department of Pathology and Cytology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia
Ivan Pezelj orcid id orcid.org/0000-0001-7083-7672 ; Department of Urology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia
Božo Krušlin orcid id orcid.org/0000-0002-0480-1687 ; Ljudevit Jurak Department of Pathology and Cytology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia; Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia


Puni tekst: engleski pdf 201 Kb

str. 12-15

preuzimanja: 237

citiraj


Sažetak

Prostatic adenocarcinoma (PC) comprises around 19% of malignancies in Croatian male population. On the basis of PSA value, Gleason score, grading group and clinical stage, PC can be classified into low- and high-risk groups which is significant for different therapeutic regimens and prognostic outcomes. In this retrospective study, we analyzed the difference in preoperative PSA value in a group of 272 patients who underwent radical prostatectomy and were diagnosed with PC adenocarcinoma in our institution in a period from January 1st, 2018 untill December 31st, 2018. Subsequently, they were divided into low- and high-risk prostatic adenocarcinoma groups. Our results demonstrated positive correlation in preoperative PSA values between the groups and therefore support the use of PSA as one of the parameters in defining low- and high-risk prostatic adenocarcinoma categories.

Ključne riječi

Prostatic Adenocarcinoma; PSA; Gleason Grade; Low-risk; High-risk

Hrčak ID:

233411

URI

https://hrcak.srce.hr/233411

Datum izdavanja:

1.11.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 975 *